10.01 Prostanoid-insensitive chimeric antigen receptor modified T cells mediate therapeutic efficacy in solid cancer models by J Dorr, S Stock, S Kobold, S Michaelides, S Lesch, A Gottschlich, A Öner, D Briukhovetska, L Fertig, L Gregor, SB Lacher, L Majed, E Carlini, D Andreu Sanz, JP Böttcher